LivaNova PLC (NASDAQ:LIVN) had its price target boosted by investment analysts at Jefferies Group LLC from $76.00 to $80.00 in a research report issued to clients and investors on Friday. The firm currently has a “buy” rating on the stock. Jefferies Group LLC’s price objective suggests a potential upside of 17.53% from the company’s previous close.

A number of other equities analysts have also weighed in on LIVN. BidaskClub lowered shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Berenberg Bank reiterated a “buy” rating and set a $70.00 target price on shares of LivaNova PLC in a research note on Friday, August 11th. WBB Securities lowered shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 target price for the company. in a research note on Tuesday, August 15th. Needham & Company LLC started coverage on shares of LivaNova PLC in a research report on Wednesday, August 23rd. They set a “hold” rating for the company. Finally, Piper Jaffray Companies reissued an “overweight” rating and set a $75.00 price objective on shares of LivaNova PLC in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $68.67.

LivaNova PLC (NASDAQ LIVN) traded up 0.815% during trading on Friday, hitting $68.625. The stock had a trading volume of 518,027 shares. The company has a market capitalization of $3.35 billion, a P/E ratio of 122.545 and a beta of 0.58. LivaNova PLC has a 1-year low of $40.84 and a 1-year high of $69.29. The stock’s 50-day moving average price is $62.35 and its 200-day moving average price is $57.45.

LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The company had revenue of $321.40 million during the quarter, compared to analyst estimates of $315.75 million. LivaNova PLC’s revenue was up .1% on a year-over-year basis. Analysts expect that LivaNova PLC will post $3.24 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “LivaNova PLC (LIVN) PT Raised to $80.00” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/15/livanova-plc-livn-pt-raised-to-80-00.html.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $60.76, for a total transaction of $60,760.00. Following the transaction, the director now directly owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.28% of the company’s stock.

Several large investors have recently modified their holdings of LIVN. PNC Financial Services Group Inc. boosted its stake in shares of LivaNova PLC by 9.8% during the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after purchasing an additional 153 shares in the last quarter. Riverhead Capital Management LLC boosted its stake in shares of LivaNova PLC by 76.3% during the second quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after purchasing an additional 763 shares in the last quarter. Meadow Creek Investment Management LLC boosted its stake in shares of LivaNova PLC by 11.4% during the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock valued at $121,000 after purchasing an additional 252 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in shares of LivaNova PLC by 11.4% during the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock valued at $147,000 after purchasing an additional 306 shares in the last quarter. Finally, Exane Derivatives boosted its stake in shares of LivaNova PLC by 814.8% during the second quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after purchasing an additional 2,811 shares in the last quarter. 82.36% of the stock is currently owned by institutional investors and hedge funds.

LivaNova PLC Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Analyst Recommendations for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.